|
Joseph S. Jay Mohr joined Zelos as Chief Business Officer in 2006 and assumed the role of Acting Head of Finance in 2008. Prior to joining Zelos, Mr. Mohr was Chief Executive Officer and co-founder of Gloucester Pharmaceuticals, a private, clinical-stage oncology company, from 2003 to 2005. Mr. Mohr was also formerly President and Chief Business Officer at Variagenics, Inc., a publicly traded biotechnology company, from 2001 to 2003, and Executive Vice President of Serono, Inc.'s Metabolic Endocrinology Strategic Business Unit from 1997 to 2001. Prior to joining Serono, he was with Schering- Plough Corporation from 1993 to 1996, where he was responsible for the global marketing of Claritin and pre-launch activities for Nasonex . Mr. Mohr received an MBA from the Wharton School of the University of Pennsylvania and a Bachelor of Arts degree from Vanderbilt University. | 